Disrupted neuronal trafficking in amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron loss.
• Current treatments for ALS are ineffective, highlighting the need for deeper understanding of disease mechanisms.
• Recent research implicates intracellular transport defects in ALS pathogenesis.

Purpose of the Study:

• To review and discuss recent findings on intracellular transport defects in ALS.
• To explore the role of specific gene mutations (FUS, TDP-43, C9ORF72) in neuronal trafficking.
• To identify potential therapeutic avenues based on understanding these cellular mechanisms.

Main Methods:

• Literature review of recent studies on ALS and intracellular transport.
• Synthesis of evidence linking genetic mutations to trafficking deficits.
• Analysis of affected transport pathways including endosomal, autophagy, ER/Golgi, axonal, and nucleocytoplasmic transport.

Main Results:

• ALS-associated gene mutations correlate with disruptions in neuronal trafficking.
• Defects in endosomal, receptor, autophagy, and ER/Golgi trafficking are observed in ALS.
• Alterations in axonal and nucleocytoplasmic transport are significant factors in motor neuron degeneration.

Conclusions:

• Intracellular transport defects are a central mechanism in ALS.
• Understanding these defects provides critical insights into ALS pathogenesis.
• Targeting intracellular transport pathways may offer novel therapeutic strategies for ALS.